Rational design of an ex vivo model of thrombosis

Michelle A. Berny, Ishan A. Patel, Tara C. White-Adams, Patrick Simonson, Andras Gruber, Sandra Rugonyi, Owen McCarty

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The underlying pathogenesis of cardiovascular disease is the formation of occlusive thrombi. While many well-defined animal models recapitulate the process of intravascular thrombosis, there is a need for validated ex vivo models of occlusive thrombus formation. Using the force of gravity to provide a constant pressure gradient, we designed and validated an ex vivo model of thrombosis. Times to occlusion on a collagen matrix in our model were within the range of occlusion times observed in murine thrombosis models. Prolongation of time to occlusion in the presence of platelet αIIbβ 3 antagonists or inhibitors to thrombin or activated factor X is in agreement with established mechanisms of thrombus formation. The use of this model may be expanded to characterize the mechanisms of thrombosis and to determine the efficacy of pharmacological agents designed to prevent occlusive thrombus formation.

Original languageEnglish (US)
Pages (from-to)187-189
Number of pages3
JournalCellular and Molecular Bioengineering
Volume3
Issue number2
DOIs
StatePublished - Jun 2010

Fingerprint

Thrombosis
Occlusion
Animal Model
Platelets
Model
Prolongation
Collagen
Pressure Gradient
Factor Xa
Inhibitor
Well-defined
Efficacy
Pressure gradient
Gravity
Thrombin
Design
Gravitation
Animals
Cardiovascular Diseases
Blood Platelets

Keywords

  • Coagulation
  • Platelets
  • Shear
  • Thrombosis model

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Modeling and Simulation

Cite this

Rational design of an ex vivo model of thrombosis. / Berny, Michelle A.; Patel, Ishan A.; White-Adams, Tara C.; Simonson, Patrick; Gruber, Andras; Rugonyi, Sandra; McCarty, Owen.

In: Cellular and Molecular Bioengineering, Vol. 3, No. 2, 06.2010, p. 187-189.

Research output: Contribution to journalArticle

Berny, Michelle A. ; Patel, Ishan A. ; White-Adams, Tara C. ; Simonson, Patrick ; Gruber, Andras ; Rugonyi, Sandra ; McCarty, Owen. / Rational design of an ex vivo model of thrombosis. In: Cellular and Molecular Bioengineering. 2010 ; Vol. 3, No. 2. pp. 187-189.
@article{60eca8a81d0942dfb2c65b32d480fed5,
title = "Rational design of an ex vivo model of thrombosis",
abstract = "The underlying pathogenesis of cardiovascular disease is the formation of occlusive thrombi. While many well-defined animal models recapitulate the process of intravascular thrombosis, there is a need for validated ex vivo models of occlusive thrombus formation. Using the force of gravity to provide a constant pressure gradient, we designed and validated an ex vivo model of thrombosis. Times to occlusion on a collagen matrix in our model were within the range of occlusion times observed in murine thrombosis models. Prolongation of time to occlusion in the presence of platelet αIIbβ 3 antagonists or inhibitors to thrombin or activated factor X is in agreement with established mechanisms of thrombus formation. The use of this model may be expanded to characterize the mechanisms of thrombosis and to determine the efficacy of pharmacological agents designed to prevent occlusive thrombus formation.",
keywords = "Coagulation, Platelets, Shear, Thrombosis model",
author = "Berny, {Michelle A.} and Patel, {Ishan A.} and White-Adams, {Tara C.} and Patrick Simonson and Andras Gruber and Sandra Rugonyi and Owen McCarty",
year = "2010",
month = "6",
doi = "10.1007/s12195-010-0103-5",
language = "English (US)",
volume = "3",
pages = "187--189",
journal = "Cellular and Molecular Bioengineering",
issn = "1865-5025",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Rational design of an ex vivo model of thrombosis

AU - Berny, Michelle A.

AU - Patel, Ishan A.

AU - White-Adams, Tara C.

AU - Simonson, Patrick

AU - Gruber, Andras

AU - Rugonyi, Sandra

AU - McCarty, Owen

PY - 2010/6

Y1 - 2010/6

N2 - The underlying pathogenesis of cardiovascular disease is the formation of occlusive thrombi. While many well-defined animal models recapitulate the process of intravascular thrombosis, there is a need for validated ex vivo models of occlusive thrombus formation. Using the force of gravity to provide a constant pressure gradient, we designed and validated an ex vivo model of thrombosis. Times to occlusion on a collagen matrix in our model were within the range of occlusion times observed in murine thrombosis models. Prolongation of time to occlusion in the presence of platelet αIIbβ 3 antagonists or inhibitors to thrombin or activated factor X is in agreement with established mechanisms of thrombus formation. The use of this model may be expanded to characterize the mechanisms of thrombosis and to determine the efficacy of pharmacological agents designed to prevent occlusive thrombus formation.

AB - The underlying pathogenesis of cardiovascular disease is the formation of occlusive thrombi. While many well-defined animal models recapitulate the process of intravascular thrombosis, there is a need for validated ex vivo models of occlusive thrombus formation. Using the force of gravity to provide a constant pressure gradient, we designed and validated an ex vivo model of thrombosis. Times to occlusion on a collagen matrix in our model were within the range of occlusion times observed in murine thrombosis models. Prolongation of time to occlusion in the presence of platelet αIIbβ 3 antagonists or inhibitors to thrombin or activated factor X is in agreement with established mechanisms of thrombus formation. The use of this model may be expanded to characterize the mechanisms of thrombosis and to determine the efficacy of pharmacological agents designed to prevent occlusive thrombus formation.

KW - Coagulation

KW - Platelets

KW - Shear

KW - Thrombosis model

UR - http://www.scopus.com/inward/record.url?scp=77955664685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955664685&partnerID=8YFLogxK

U2 - 10.1007/s12195-010-0103-5

DO - 10.1007/s12195-010-0103-5

M3 - Article

VL - 3

SP - 187

EP - 189

JO - Cellular and Molecular Bioengineering

JF - Cellular and Molecular Bioengineering

SN - 1865-5025

IS - 2

ER -